“bill-melinda-gates-foundation” Archives

in
Entry Author Date Location
Just Biotherapeutics Secures $14,000,000 Series A Funding 07/26/16 Seattle
Investor Survey, Part 2: A Pair of Seattle VCs on 2016 Themes 02/22/16 Seattle
BetterLesson Grabs $6M to Make Teacher Development More Personal 02/16/16 Boston
Affinivax Obtains $2,500,000 New Funding Round 02/05/16 Boston
UW Researchers Work on Financial Services for the Developing World 01/27/16 Seattle
Atreca Lands $56,000,000 Series A Funding Round 11/05/15 San Francisco
Budding UW Data Scientists Use Their Powers for Social Good 08/24/15 Seattle
AgBiome Obtains $34,500,000 Series B Funding Round 08/20/15 Raleigh Durham
Editas Medicine Garners $120,000,000 New Funding 08/10/15 Boston
Invest NW Would Help Rich Families Make Local Impact Investments 07/16/15 Seattle
Join Us May 6 at the Hutch to Discuss Seattle Biotech’s Wild Ride 04/14/15 Seattle
From Iceland to White House, Precision Medicine’s Promises & Hurdles 03/31/15 National
West Coast Biotech Roundup: Juno, Nektar, Kite, Glooko & More 03/19/15 Seattle
West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More 03/05/15 San Francisco
Sisu Global Health Wins $250K Grant, Launches Indiegogo Campaign 12/22/14 Detroit Ann Arbor
Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech 10/30/14 Boston
Engaged Learning, Backed by Gates Foundation, Adapts to Each Student 05/20/14 Seattle
Seattle Roundup: Tidal Turbine, IDRI, Tango Card, Codementor, TAGS 04/04/14 Seattle
Seattle BioMed Nabs $10M NIAID Grant to Develop HIV Vaccines 03/10/14 Seattle
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
IDRI CEO Stewart Parker Steps Down, Erik Iverson Steps Up 12/19/13 Seattle
Seattle Startup Koru Takes On Tech Training, Hiring for Recent Grads 12/18/13 Seattle
Gates Foundation Gets UCSF Chief Desmond-Hellmann as New CEO 12/17/13 Seattle
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Building Biotechs to Last: See the Agenda for Monday 12/05/13 San Francisco
Visterra Adds $8M, Ex-Amag Execs, To Begin Clinical Push for Flu Antibody 12/02/13 Boston
Visterra Obtains $8,100,000 Series A Financing 12/02/13 Boston
San Diego Life Sciences Roundup: Orexigen, Avalon, GSK, and More 11/27/13 San Diego
Gates Foundation Health Chief on Coaxing Pharma to Do Good (Part 2) 11/26/13 National
Gates Foundation Health Chief on Coaxing Pharma to Do Good 11/25/13 National
Page 1 of 6 next page »